Eran Elinav

Eran Elinav has revealed the functional significance of the intratumoral microbiome, demonstrating that bacteria residing within tumors directly modulate anti-cancer immune responses and drug metabolism. His work on the microbiome-inflammasome axis has shown how dysbiotic microbiome compositions activate pro-tumorigenic inflammation. His personalized microbiome medicine approach, integrating individual microbiome composition with host genetics and diet, has established the framework for precision microbiome-based cancer therapy.